Stock CTKB CYTEK BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Cytek Biosciences, Inc.

Equities

CTKB

US23285D1090

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-21 EDT 		5-day change 1st Jan Change
5.73 USD +5.14% Intraday chart for Cytek Biosciences, Inc. +1.96% -37.17%
06-12 Cytek Biosciences to Seek M&A CI
06-12 Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 09:20 AM

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cytek Biosciences Announces $50 Million Stock Repurchase Program
GL
Cytek Biosciences Announces $50 Million Stock Repurchase Program
AQ
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
GL
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
GL
Cytek Biosciences : ® Biosciences Adds Ability to Detect Subcellular Par ...
PU
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
GL
Cytek Biosciences Reports First Quarter 2024 Financial Results
GL
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
GL
Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024
GL
Cytek® Biosciences Names William McCombe Chief Financial Officer
GL
Cytek® Biosciences Names William McCombe Chief Financial Officer
AQ
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
GL
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
AQ
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
GL
Cytek Biosciences to Participate in Upcoming Investor Conferences
GL
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
GL
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
GL
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
GL
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
AQ
Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTKB Stock
  4. News Cytek Biosciences, Inc.
  5. Press Releases